Paxlovid is an antiviral pill developed to treat COVID-19 and is manufactured by Pfizer. Its use was approved, on December 22, 2021, by the FDA.
Pfizer’s anticovid pill has an active protease inhibitor Nirmatrelvir and a 100mg dose of Ritonavir. It was shown to be 89% effective in preventing high-risk patients from developing a more severe form of COVID-19, that’s only if consumed within three days of symptom onset.
Who can use Paxlovid?
The treatment was approved for use in patients over the age of 12 with COVID-19, either because they are more vulnerable to severe illness, age, or have medical conditions such as obesity or diabetes.
How is it used?
The correct thing is that the pill is prescribed by a doctor and Pfizer warned that it is better to avoid mixing the drug with other drugs. Some medications may be contraindicated while using Paxlovid, said a statement from the pharmaceutical company Pfizer.
Who should not use Pfizer’s anticovid pill?
Paxlovid is not licensed for use to prevent COVID-19. Nor was it intended for the initiation of treatment in those people who require hospitalization because they have become seriously ill.
Biden tests positive for COVID-19 again after Paxlovid rebound
- The antiviral cocktail could have serious and life-threatening interactions with medications such as blood thinners, statins and depressants.
- Pfizer’s pill is not recommended for patients with severe kidney or liver problems.
- From Pfizer they recalled that before starting treatment with COVID-19 pills, the risks and benefits of using the pill should be considered before starting to use it.
- “Healthcare professionals should be aware of potential drug interactions before and during treatment with Paxlovid and review interacting medications,” a Pfizer spokesperson told The Hill.
–
